Last reviewed · How we verify
compound E Jiao Jiang(cEJJ)
compound E Jiao Jiang(cEJJ) is a Small molecule drug developed by DongE E Jiao Coporation Limited. It is currently FDA-approved for Blood deficiency and yin deficiency syndromes, Cough and dry lung conditions, Hemostasis support. Also known as: ferrous succinate tablet（1 tablet at a time, 2 times a day, should be taken in the morning, after dinner or during meals.）.
Compound E Jiao Jiang is a traditional Chinese medicine preparation derived from donkey-hide gelatin that nourishes blood and yin to address deficiency-related conditions.
Compound E Jiao Jiang (cEJJ) is a small molecule being studied in a clinical trial for the treatment of postpartum anemia. The trial is a multicenter, randomized, double-blind, parallel controlled study to evaluate the efficacy and safety of cEJJ.
At a glance
| Generic name | compound E Jiao Jiang(cEJJ) |
|---|---|
| Also known as | ferrous succinate tablet（1 tablet at a time, 2 times a day, should be taken in the morning, after dinner or during meals.） |
| Sponsor | DongE E Jiao Coporation Limited |
| Modality | Small molecule |
| Therapeutic area | Traditional Chinese Medicine / Hematology |
| Phase | FDA-approved |
Mechanism of action
E Jiao (donkey-hide gelatin) is a classical Chinese medicinal ingredient traditionally used to tonify blood, nourish yin, and moisten the lungs. The compound formulation combines E Jiao with other herbal components to enhance these restorative effects. It is believed to work through nutritive and hemostatic mechanisms rather than through targeted molecular pathways.
Approved indications
- Blood deficiency and yin deficiency syndromes
- Cough and dry lung conditions
- Hemostasis support
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- compound E Jiao Jiang(cEJJ) CI brief — competitive landscape report
- compound E Jiao Jiang(cEJJ) updates RSS · CI watch RSS
- DongE E Jiao Coporation Limited portfolio CI
Frequently asked questions about compound E Jiao Jiang(cEJJ)
What is compound E Jiao Jiang(cEJJ)?
How does compound E Jiao Jiang(cEJJ) work?
What is compound E Jiao Jiang(cEJJ) used for?
Who makes compound E Jiao Jiang(cEJJ)?
Is compound E Jiao Jiang(cEJJ) also known as anything else?
What development phase is compound E Jiao Jiang(cEJJ) in?
Related
- Manufacturer: DongE E Jiao Coporation Limited — full pipeline
- Therapeutic area: All drugs in Traditional Chinese Medicine / Hematology
- Indication: Drugs for Blood deficiency and yin deficiency syndromes
- Indication: Drugs for Cough and dry lung conditions
- Indication: Drugs for Hemostasis support
- Also known as: ferrous succinate tablet（1 tablet at a time, 2 times a day, should be taken in the morning, after dinner or during meals.）
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing